LFVN News & Events

LifeVantage announced that after nine years at LifeVantage, Steve Fife, president, CEO and a member of the board of directors, has decided to retire in April. Fife will continue in his role as president and CEO during the transition period to ensure business continuity through his retirement date. The board is conducting an executive search and anticipates announcing the new CEO in the coming months.

Consensus $1.05. Cuts FY26 revenue view to $185M-$200M from $225M-$240M, consensus $227.51M. Cuts FY26 adjusted EBITDA view to $15M-$19M from $23M-$26M. The company said, "The Company anticipates fiscal 2026 revenue in the range of $185 million to $200 million, adjusted EBITDA of $15 million to $19 million, and adjusted earnings per share in the range of $0.60 to $0.80. The Company expects a full year tax rate of approximately 22% to 24%. This guidance reflects the current trends in the business and the Company's strategic initiatives, including international expansion and new product launches. The Company's guidance for adjusted non-GAAP EBITDA and adjusted non-GAAP earnings per diluted share excludes any non-operating or non-recurring expenses that may materialize during fiscal 2026."

Reports Q2 revenue $48.93M, consensus $54.4M. "The second quarter reflected challenging competitive dynamics in the weight loss market as we cycled the launch of our MindBody GLP-1 System in October 2024," said Steve Fife, President and CEO of LifeVantage. "We acknowledge that our performance during the quarter did not meet your expectations or ours and we are redoubling our efforts to stabilize our GLP-1 business and make the other changes necessary to return to revenue growth. While the growth trajectory of MindBody may have changed, we remain committed to this proven, scientifically validated natural weight loss solution."